Novartis, Roche’s Food Allergies Treatment Xolair Gets FDA Approval
Wall Street Journal
Novartis and Roche Holding said the U.S. Food and Drug Administration approved their Xolair treatment to reduce allergic reactions following the exposure to one or more foods.